News & Research
First New Game-Changer for Aortic Valve Stenosis Patients in 40 Years
Esther Jane Cremean is happy to share her secret to living a long, happy life: “Laugh and have fun,” says the 85-year-old mother, grandmother, and great grandmother.
But she doesn’t discount the role that skilled doctors and breakthrough surgical innovations have also played in her life.
Cremean’s health became concerning to her primary physician who had been monitoring a heart murmur, discovered years ago. With the murmur sounding louder at her yearly exam last October, Cremean’s doctor ordered an echocardiogram along with a few other tests.
Several days later, an unexpected call from her area hospital requested Cremean come in for additional testing, followed by a consultation with a cardiologist.
An unexpected diagnosis
“The doctor told me I had a very large aortic aneurysm and aortic valve stenosis,” Cremean says, noting that she hadn’t experienced symptoms other than slight fatigue. But nothing that prevented her from keeping up with daily housework and yardwork.
To complicate matters, Cremean was also diagnosed with a bicuspid aortic valve, a congenital defect often going undiscovered until later in life. The aortic valve in a typical healthy heart has three flexible leaflets (also known as flaps or cusps) that open and close to send oxygenated blood from the heart to the aorta. A person with a bicuspid aortic valve has only two leaflets. Over time, the bicuspid aortic valve leaflets can thicken and calcify, a condition known as aortic valve stenosis. When this happens, the heart is forced to pump harder than usual to get blood through the very narrowed valve and into the body.
An aortic aneurysm, or enlargement of the ascending aorta, is another complication of a bicuspid aortic valve.
Cremean was challenged with both. “I had to make a decision about what to do,” she said.
Given her age and condition, surgery would be risky. The initial recommendation was for a transcatheter aortic valve replacement, or TAVR procedure. During this minimally invasive surgery, the aortic valve is accessed via a catheter guided through the femoral artery. The valve is then replaced without the need for an open-heart procedure.
Breakthrough technique developed at U-M
Cremean was referred to the University of Michigan Health Frankel Cardiovascular Center where she met with Bo Yang, M.D., associate professor of surgery. During their telehealth visit, Cremean discovered she wasn’t a candidate for TAVR.
“TAVR was not an option because of the patient’s large aneurysm and very small aortic root and aortic valve annulus (the base of the aortic root),” said Yang, who has developed a novel procedure to enlarge a patient’s aortic root and valve annulus by 3 or 4 valve sizes to accommodate a new and much larger prosthetic valve.
Known as the Y-incision/rectangular patch root enlargement, “The procedure enlarges the size of the ‘door’ (the valve) and the ‘house’ (aortic root). We make the house bigger so we can add a bigger door to allow the blood to flow better,” explained Yang. “We put new walls on the house by using a rectangular patch made of synthetic material to enlarge the house (aortic root).”
Yang has trained surgeons throughout the world to perform this breakthrough technique. The first such development in open heart surgery in more than 40 years, it allows patients who would not typically be candidates for a larger valve, due to the small size of their aortic root and annulus, to have their aortic valve successfully replaced with a much larger prosthetic valve.
“It’s more effective than traditional procedures such as Nicks and Manouguian, which enlarge the aortic root by only up to 1 or 2 sizes, and is simpler than the Manouguian procedure,” Yang said of his game-changing procedure. “It also causes no damage to surrounding areas of the heart, including the mitral valve, the chambers of the heart, and the heart’s conducting system.”
Yang is one of the executive directors of a new program that is supporting innovations like the Y-incision procedure. MI-AORTA is an enhanced aortic program that consolidates current aortic disease clinical practice, training, and research. The program is made possible by a generous, anonymous donation and aims to transform Michigan Medicine’s highly reputable multi-disciplinary aortic program into one that is world-renowned.
Some of the other goals of MI-AORTA are to facilitate collaboration and ensure that current systems work more effectively together, to develop cutting edge and novel treatments of aortic diseases, and to share knowledge gained from unique longitudinal databases that impact population health.
Another aim of the program is to create value for patients like Cremean and for the families and communities that Michigan Medicine serves.
Heart valve increased by three sizes
Cremean said she didn’t have to think twice about undergoing surgery last February, despite the fact that it would be an open-heart procedure. “My decision was easy once I met with Dr. Yang. He was very consoling,” she said.
Nearly seven months post-surgery, “The patient is very strong and doing well,” said Yang. “We increased her aortic annulus by three valve sizes — from size 21 to 27 — to give her a much bigger valve, which significantly improved blood flow, and also repaired her aneurysm.”
Yang expects Cremean’s open heart procedure will allow her to continue living a healthy, active life. Looking ahead, the increase in the size of her aortic root and valve “sets her up for a future minimally invasive TAVR procedure, if needed.”
Cremean said she’s recovered remarkably well from her surgery and is enjoying her life. “I’m still living alone and doing my own thing,” said the woman who advocates for laughing and having fun — and who feels she found the right doctor at the right time.
“Dr. Yang is such a good guy. He’s so much fun.” But more important, she said, “He’s a skilled doctor with so much compassion.”